Lifestyle Medicine and Dermatology with Dr. Heather Woolery-Lloyd
lifestyle medicineNext Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Heather Woolery-Lloyd, who is board certified in both dermatology and lifestyle medicine. Watch as she shares the six major pillars of lifestyle medicine, and which dermatologic conditions are shown to be influenced by lifestyle factors. You may change how you counsel your patients after watching this video!   F …
lifestyle medicine
JDD February 2023 Issue Highlights
The February issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and brief communications exploring topics such as efficacy and safety of 1% clascoterone cream in patients aged ≥12 years with acne vulgaris, dupilumab’s impact on atopic dermatitis among adolescent and adult patients, development and validation of a photonumeric scale …
Lesson From Residency Translated
residencyNext Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Adam Friedman, professor and chair of dermatology at GW School of Medicine and Health Sciences, on life lessons from his residency and career. Dr. Friedman provides his tips for remaining calm during the craziest of office visits. …
residency
Patient Buzz Series: Gel Manicure Safety
gel manicure safetyA study on the safety of UV lights during gel manicures is the most popular dermatology topic in the consumer press this month. Dermatologists have long been concerned that routine gel manicures with UV lights would be associated with a higher risk of skin cancer. A study in Nature Communications demonstrates that the radiation emitted by these UV nail polish dryers does damage DNA and cause perma …
gel manicure safety
The “Flolan Rash” | Great Cases from the JDD
Flolan RashINTRODUCTION Epoprostenol (Flolan) is a last-resort intravenous (IV) medication for the treatment of severe pulmonary arterial hypertension (PAH). Cutaneous adverse events of Flolan are well-known by pulmonologists, though lacking in dermatologic literature.1 We report an extensive near erythrodermic appearing asymptomatic eruption following long-term use of epoprostenol. This characteristic and …
Flolan Rash